PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-77.16%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-68.85%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-107.08%
Negative EBIT growth while 4997.T is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-105.50%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-126.00%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-126.00%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-126.00%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-86.85%
Negative 10Y revenue/share CAGR while 4997.T stands at 25.13%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-86.85%
Negative 5Y CAGR while 4997.T stands at 25.13%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-86.85%
Negative 3Y CAGR while 4997.T stands at 25.13%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
92.83%
Net income/share CAGR at 50-75% of 4997.T's 133.28%. Martin Whitman might question if the firm’s product or cost base lags behind.
92.83%
5Y net income/share CAGR at 50-75% of 4997.T's 133.28%. Martin Whitman might see a shortfall in operational efficiency or brand power.
92.83%
3Y net income/share CAGR 50-75% of 4997.T's 133.28%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Firm’s AR is declining while 4997.T shows 4.82%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
114.13%
We show growth while 4997.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
6.84%
Asset growth above 1.5x 4997.T's 0.52%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-10.09%
We have a declining book value while 4997.T shows 1.11%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
19.17%
Debt shrinking faster vs. 4997.T's 47.87%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.